JP Stock MarketDetailed Quotes

3349 COSMOS Pharmaceutical

Watchlist
  • 11655.0
  • 0.00.00%
20min DelayMarket to Open Jul 16 15:00 JST
466.21BMarket Cap18.88P/E (Static)

COSMOS Pharmaceutical Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)May 31, 2024
(Q4)May 31, 2024
(Q3)Feb 29, 2024
(Q2)Nov 30, 2023
(Q1)Aug 31, 2023
(FY)May 31, 2023
(Q4)May 31, 2023
(Q3)Feb 28, 2023
(Q2)Nov 30, 2022
(Q1)Aug 31, 2022
Total revenue
16.59%964.99B
12.77%249.68B
18.09%238.88B
18.64%234.78B
17.24%241.65B
9.57%827.7B
12.65%221.4B
7.74%202.29B
8.90%197.89B
8.82%206.12B
Cost of revenue
17.86%776.68B
13.59%201.04B
19.21%192.15B
20.31%188.86B
18.81%194.64B
9.11%658.98B
13.07%176.99B
7.11%161.19B
7.87%156.97B
8.20%163.83B
Gross profit
11.61%188.31B
9.53%48.64B
13.72%46.73B
12.21%45.92B
11.16%47.01B
11.40%168.72B
11.04%44.41B
10.30%41.1B
13.02%40.92B
11.33%42.29B
Operating expense
13.14%156.8B
12.16%40.88B
13.16%38.83B
13.47%39.07B
13.86%38.02B
13.92%138.59B
13.56%36.45B
13.10%34.32B
15.62%34.43B
13.46%33.39B
Operating profit
4.55%31.5B
-2.51%7.76B
16.53%7.9B
5.55%6.85B
1.02%8.99B
1.12%30.13B
0.81%7.96B
-1.99%6.78B
0.98%6.49B
4.02%8.9B
Net non-operating interest income (expenses)
-1,275.00%-55M
-600.00%-35M
-700.00%-6M
-700.00%-6M
-700.00%-8M
-4M
-350.00%-5M
1M
200.00%1M
0.00%-1M
Non-operating interest income
-6.38%44M
-8.33%11M
0.00%12M
-8.33%11M
-9.09%10M
-9.62%47M
-14.29%12M
-7.69%12M
-7.69%12M
-8.33%11M
Non-operating interest expense
94.12%99M
170.59%46M
63.64%18M
54.55%17M
50.00%18M
-1.92%51M
41.67%17M
-15.38%11M
-21.43%11M
-7.69%12M
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)
-86.17%-579M
-300.66%-609M
723.08%162M
21.11%-71M
-41.86%-61M
-266.31%-311M
-38.18%-152M
-116.88%-26M
-139.30%-90M
50.00%-43M
Less:Restructuring and mergern&acquisition
-63.49%69M
-63.83%51M
-311.11%-19M
-58.33%10M
80.00%27M
20.38%189M
95.83%141M
-79.07%9M
-40.00%24M
650.00%15M
Less:Other special charges
-120.49%-25M
109.09%23M
-941.18%-143M
-7.58%61M
21.43%34M
135.47%122M
-71.05%11M
108.63%17M
124.54%66M
-66.67%28M
Less:Write off
--535M
----
----
----
----
----
----
----
----
----
Other non-operating income (expenses)
-3.61%2.85B
-10.34%659M
-5.35%672M
2.28%807M
-1.52%715M
-3.46%2.96B
-14.83%735M
3.35%710M
2.33%789M
-2.55%726M
Income before tax
2.89%33.72B
-8.95%7.78B
16.89%8.73B
5.49%7.58B
0.57%9.64B
-0.83%32.77B
-1.27%8.54B
-3.78%7.47B
-3.23%7.18B
3.99%9.58B
Income tax
3.23%9.27B
-33.69%681M
19.17%2.96B
5.54%2.5B
0.94%3.13B
-9.27%8.98B
-47.33%1.03B
-2.70%2.48B
-2.27%2.37B
4.38%3.1B
Net income
2.76%24.45B
-5.55%7.1B
15.77%5.77B
5.42%5.08B
0.42%6.51B
2.77%23.8B
12.15%7.51B
-4.34%4.98B
-3.68%4.82B
3.81%6.48B
Net income continuous operations
2.76%24.45B
-5.56%7.1B
15.75%5.77B
5.46%5.08B
0.40%6.51B
2.77%23.8B
12.13%7.51B
-4.30%4.99B
-3.70%4.82B
3.81%6.48B
Noncontrolling interests
Net income attributable to the company
2.76%24.45B
-5.55%7.1B
15.77%5.77B
5.42%5.08B
0.42%6.51B
2.77%23.8B
12.15%7.51B
-4.34%4.98B
-3.68%4.82B
3.81%6.48B
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
2.76%24.45B
-5.55%7.1B
15.77%5.77B
5.42%5.08B
0.42%6.51B
2.77%23.8B
12.15%7.51B
-4.34%4.98B
-3.68%4.82B
3.81%6.48B
Gross dividend payment
Basic earnings per share
2.71%617.22
-5.62%179.08
15.67%145.61
5.36%128.18
0.41%164.35
2.77%600.96
12.14%189.74
-4.32%125.88
-3.68%121.66
3.81%163.68
Diluted earnings per share
2.71%617.22
-5.62%179.08
15.68%145.601
5.36%128.18
0.41%164.35
2.77%600.96
12.14%189.74
-4.34%125.862
-3.68%121.66
3.81%163.68
Dividend per share
20.00%120
4.35%60
0
41.18%60
0
25.00%100
43.75%57.5
0
6.25%42.5
0
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(FY)May 31, 2024(Q4)May 31, 2024(Q3)Feb 29, 2024(Q2)Nov 30, 2023(Q1)Aug 31, 2023(FY)May 31, 2023(Q4)May 31, 2023(Q3)Feb 28, 2023(Q2)Nov 30, 2022(Q1)Aug 31, 2022
Total revenue 16.59%964.99B12.77%249.68B18.09%238.88B18.64%234.78B17.24%241.65B9.57%827.7B12.65%221.4B7.74%202.29B8.90%197.89B8.82%206.12B
Cost of revenue 17.86%776.68B13.59%201.04B19.21%192.15B20.31%188.86B18.81%194.64B9.11%658.98B13.07%176.99B7.11%161.19B7.87%156.97B8.20%163.83B
Gross profit 11.61%188.31B9.53%48.64B13.72%46.73B12.21%45.92B11.16%47.01B11.40%168.72B11.04%44.41B10.30%41.1B13.02%40.92B11.33%42.29B
Operating expense 13.14%156.8B12.16%40.88B13.16%38.83B13.47%39.07B13.86%38.02B13.92%138.59B13.56%36.45B13.10%34.32B15.62%34.43B13.46%33.39B
Operating profit 4.55%31.5B-2.51%7.76B16.53%7.9B5.55%6.85B1.02%8.99B1.12%30.13B0.81%7.96B-1.99%6.78B0.98%6.49B4.02%8.9B
Net non-operating interest income (expenses) -1,275.00%-55M-600.00%-35M-700.00%-6M-700.00%-6M-700.00%-8M-4M-350.00%-5M1M200.00%1M0.00%-1M
Non-operating interest income -6.38%44M-8.33%11M0.00%12M-8.33%11M-9.09%10M-9.62%47M-14.29%12M-7.69%12M-7.69%12M-8.33%11M
Non-operating interest expense 94.12%99M170.59%46M63.64%18M54.55%17M50.00%18M-1.92%51M41.67%17M-15.38%11M-21.43%11M-7.69%12M
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges) -86.17%-579M-300.66%-609M723.08%162M21.11%-71M-41.86%-61M-266.31%-311M-38.18%-152M-116.88%-26M-139.30%-90M50.00%-43M
Less:Restructuring and mergern&acquisition -63.49%69M-63.83%51M-311.11%-19M-58.33%10M80.00%27M20.38%189M95.83%141M-79.07%9M-40.00%24M650.00%15M
Less:Other special charges -120.49%-25M109.09%23M-941.18%-143M-7.58%61M21.43%34M135.47%122M-71.05%11M108.63%17M124.54%66M-66.67%28M
Less:Write off --535M------------------------------------
Other non-operating income (expenses) -3.61%2.85B-10.34%659M-5.35%672M2.28%807M-1.52%715M-3.46%2.96B-14.83%735M3.35%710M2.33%789M-2.55%726M
Income before tax 2.89%33.72B-8.95%7.78B16.89%8.73B5.49%7.58B0.57%9.64B-0.83%32.77B-1.27%8.54B-3.78%7.47B-3.23%7.18B3.99%9.58B
Income tax 3.23%9.27B-33.69%681M19.17%2.96B5.54%2.5B0.94%3.13B-9.27%8.98B-47.33%1.03B-2.70%2.48B-2.27%2.37B4.38%3.1B
Net income 2.76%24.45B-5.55%7.1B15.77%5.77B5.42%5.08B0.42%6.51B2.77%23.8B12.15%7.51B-4.34%4.98B-3.68%4.82B3.81%6.48B
Net income continuous operations 2.76%24.45B-5.56%7.1B15.75%5.77B5.46%5.08B0.40%6.51B2.77%23.8B12.13%7.51B-4.30%4.99B-3.70%4.82B3.81%6.48B
Noncontrolling interests
Net income attributable to the company 2.76%24.45B-5.55%7.1B15.77%5.77B5.42%5.08B0.42%6.51B2.77%23.8B12.15%7.51B-4.34%4.98B-3.68%4.82B3.81%6.48B
Preferred stock dividends
Other under preferred stock dividend 0000000000
Net income attributable to common stockholders 2.76%24.45B-5.55%7.1B15.77%5.77B5.42%5.08B0.42%6.51B2.77%23.8B12.15%7.51B-4.34%4.98B-3.68%4.82B3.81%6.48B
Gross dividend payment
Basic earnings per share 2.71%617.22-5.62%179.0815.67%145.615.36%128.180.41%164.352.77%600.9612.14%189.74-4.32%125.88-3.68%121.663.81%163.68
Diluted earnings per share 2.71%617.22-5.62%179.0815.68%145.6015.36%128.180.41%164.352.77%600.9612.14%189.74-4.34%125.862-3.68%121.663.81%163.68
Dividend per share 20.00%1204.35%60041.18%60025.00%10043.75%57.506.25%42.50
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
JP
Overall
Symbol
Latest Price
%Chg